Abstract Giant cell tumour (GCT) remains one of the most obscure and intensely studied bone tumours. In an effort to resolve questions regarding the genesis and clinical outcome of GCT, advances have been made recently in the identification of chromosomal abnormalities implicated in the tumour. Fusion of telomeres is very frequent in GCT, and this process may be associated with chromosome instability and tumour development. However, little emphasis has been placed on chromosomal imbalances in the molecular characterization of this disease. Here, we report the case of an 83-year-old woman diagnosed with GCT where local recurrence was observed after 11 months of the resection. Cytogenetic studies of the GCT showed a modal number of 46 chromosomes with telomeric associations on 11p and dicentric chromosomes. Moreover, clonal abnormalities, such as del(17p) and losses of chromosomes 4, 13 and 18 and gains on chromosome 7, were also detected. Interestingly, comparative genomic hybridisation (CGH) analysis revealed chromosomal imbalances with gains on chromosomes 1p31-q44, 6q12-q23 and 12q15-q22. Thus, the use of CGH expanded the information obtained by conventional cytogenetics and demonstrated that chromosomal imbalances were associated with the recurrence of the GCT.
Introduction
Giant cell tumour (GCT) represents approximately 4% of all bone tumours and typically occurs in young women, although it has been observed in older subjects [17] . GCT preferentially involves the ends of the long bones and is characterized morphologically by three types of cells: (a) multinucleated giant cells-predominant type, (b) cells with a round morphology resembling monocytes and (c) spindle-shaped, fibroblast-like stromal cells. Recently, it has been suggested that the stromal cells may form a part of the neoplastic component, while the other cell types serve simply as the reactive component [11, 18] . Although 80% of GCTs is benign, local recurrences and metastases can occur, even in cases with a previous benign histology [9, 16] . For this reason, the WHO has classified GCT as an aggressive and potentially malignant lesion [3] . Clearly, histological features are not sufficient to predict the clinical outcome of this tumour, and other parameters are needed for an accurate prognosis.
The most recurrent karyotypic findings in GCT are telomeric associations (tas) that usually affect 11p, 15p, 19q and 21p [17] , while numerical alterations are infrequently detected by conventional cytogenetic analysis [10] . This genetic profile differs from other bone tumours in which chromosomal imbalances (e.g. chondrosarcoma, osteosarcoma and chondroma) or recurrent structural rearrangements (e.g. Ewing sarcoma, aneurismal bone cysts and chondroma) are more frequent [10] . In the present study, we have analysed a recurrent GCT by comparative genomic hybridisation (CGH), which permitted us to detect extensive chromosomal imbalances. This novel observation suggests that chromosomal imbalances may predict recurrence of GCT, and thus, our study not only contributes to our basic understanding of this disease but it also reveals a potential new prognostic tool.
Clinical history
An 83-year-old female was evaluated for pain and immobility of her left wrist which developed over the course of 5 months and without previous trauma to the area. Radiographs revealed an osteolytic lesion in the distal epiphysis of the radius, with slightly precise edges and breakage of the cortex (Fig. 1) . The local extension of the lesion was studied through computer tomography and magnetic resonance imaging. Marginal block resection was carried out at the distal end of the radius. Reconstruction was performed with wrist arthrodeses using an allograft of fibula and fixation with a plate. Histological examination of the biopsy specimens revealed GCT (Fig. 2) . Eleven months following the resection, local recurrence in soft tissue was observed and a marginal resection was performed. Currently, the patient is free of symptoms with no evidence of tumour recurrence during a follow-up of 30 months.
Material and methods
A specimen of the biopsy was minced and disaggregated overnight in a solution of collagenase (400 UI/ml) and incubated in 3 ml DMEN/F12 (Gibco/BRL, UK) containing 10% fetal calf serum and 5% C02 atmosphere. The cytogenetic preparation and G-banding were performed according to routine cytogenetic procedures [12] .
CGH analysis was performed as previously described [7] . Briefly, tumour DNA (test DNA) was labelled with biotin-16-deoxyuridine 5-triphosphate (dUTP) (Boehringer Mannheim, Mannheim, Germany), and the reference DNA was labelled with digoxigenin-11-dUTP (Boehringer Mannheim) by a standard nick-translation reaction. Equal amounts (21 μg) of labelled tumour and normal DNAs and 70 μg of unlabelled human Cot-1 DNA (Gibco/BRL, Gaithersburg, MD, USA) were co-hybridised to slides of human metaphase chromosome spread prepared from phytohaemagglutinin-stimulated lymphocytes from normal individuals. After hybridisation for 1 to 2 days in a moist chamber at 37°C, post-hybridisation washes were performed to a stringency of 0.1× saline sodium citrate at 42°C. Tumour and normal DNA were detected by avidinfluorescein isothiocyanate and rhodamine-conjugated antidigoxigenin, respectively. These slides were counterstained with 4,6-diamidino-2-phenylindole and mounted with an anti-fade solution. Image acquisition was performed with an epifluorescence microscope (Nikon MDR1000) equipped with a cooled charge-coupled device camera. The images were analysed with Quips CGH software (QUIPS, Vysis, Downers Grove, IL, USA).
The probes used for fluorescence in situ hybridisation (FISH) analyses were LSI p53 (17p13.1) Spectrum Orange and bacterial artificial chromosome (BAC) RP-11 611O2 which contains a DNA sequence specific for the MDM2 gene locus, mapping to 12q12 (RPCI-11 Human Male BAC Library). FISH studies were carried out following well-established methods [8] .
Results
A benign tumour typically displays large numbers of evenly distributed multinucleated giant cells on a background of sheets of round to oval mononuclear cells lacking cytologic atypia and atypical mitotic figures (Fig. 2a,b) . The neoplastic cells invade locally soft tissue (Fig. 2c) .
Chromosomal analysis revealed that most cells were hypodiploidy, varying from 43 to 45 chromosomes, and the description of a representative karyotype was 41- [5] . In addition, no clonal dicentric chromosome (dic) or tas were observed on chromosomes 3p, 11p and 15q (Fig. 3) .
Genomic DNA analysis of the tumour specimen by CGH revealed gains on 1p31-q44, 2q24-q34, 3q24-26, 4p15-q34, 5q14-q23, 6q12-q23, 7q31, 8q13-q21, 12q15-q22 and 13q14-q22. The losses were detected on 9q31-q34, 11q23-25, 12q23-q24, 14q31-32, 16, 17, 20q11-q13, 21 and 22 (Fig. 4) .
Hybridisation with probe 17p showed that the 30% of cells displayed deletions of TP53 while 15% had three copies of 17p. Regarding the 12q region, all cells analysed contained two signals.
Discussion
Information about the genetic abnormalities underlying GCT has been limited to conventional cytogenetics which can identify tas and dic as the typical aberrations in this type of tumour [14] . These biomarkers, such as tas, have been implicated in chromosomal instability and tumorigenesis and could be responsible for the accumulation of other associated cytogenetic aberrations [1, 19] . However, the precise role of tas in the development of GCT and their molecular consequences are not fully understood. Along with tas, other karyotypic findings, such as clonal, structural and/or numerical changes, have been observed in GCT [3, 15] . Recently, a cytogenetic analysis of a CGT Fig. 3 reported a complex karyotype but without tas or dic aberration [11] . In the present study, we have used CGH to confirm and extend observations regarding the genetic changes associated with GCT. Clonal abnormalities were also detected in the current case and confirmed by FISH analysis. Furthermore, single or complex abnormalities could be observed. We noted changes on 17p that suggest the presence of a secondary aneurismal bone cyst component [15] ; however, there was neither histological nor radiological evidence in this case of an aneurismal component.
We have found multiple genomic changes by CGH analysis, including gains on 1p32-q44, 6q12-q25 and 12q14-q22 and losses on 17p. Several reports concerning bone/cartilage-forming lesions or benign mesenchymal tumours have demonstrated associations with changes on 6q and 12q [1, 2] . In addition, gains on 1q, 6q and 12q have been associated with a subgroup of malignant bone fibrous histiocytoma of undifferentiated status, suggesting a possible role of these genomic alterations in GCT [4] [5] [6] . Recent molecular studies performed by loss of heterozygosity (LOH) revealed the accumulation of genetic abnormalities in primary and recurrent tumours, without any difference between the two groups [13] . LOH of 17p (close to p53 locus) was also observed in primary GCT and their lung metastases. Consistent with this, we have observed deletion on 17p by both CGH and FISH analysis, suggesting that this genetic abnormality may be associated with the recurrence of the tumour.
For predicting the clinical outcome of GCT, histological classification of the tumour has a limited prognostic value [16] . Recent data suggests that cytogenetic findings could be implicated in the course of the disease [3, 4] . Moreover, chromosomal loss is the most likely molecular event to occur in this disease and may represent a biomarker(s) of tumour progression [13] . Both types of abnormalities were observed in the patient of our study, and therefore, multiple chromosomal changes detected by cytogenetics and CGH could explain the local recurrence of GCT in the soft tissue, which occurred 11 months after removal of the original tumour.
In summary, through the use of the CGH technique, we have described for the first time the presence of chromosomal imbalances in a case of GCT. Further studies will be required to fully evaluate the clinical significance of our findings and to determine the specificity of this genetic profile. 
